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Rhesus rotavirus (RRV) binds to sialic acid residues on the surface of target cells, and treatment of these cells with
neuraminidase greatly reduces virus binding with the consequent reduction of infectivity. Variants that can efficiently infect
neuraminidase-treated cells have been isolated, indicating that attachment to sialic acid is not an essential step for animal
rotaviruses to infect cells. To identify and characterize the neuraminidase-resistant receptor for rotaviruses, we have isolated
a hybridoma that secrets a monoclonal antibody (MAb) (2D9) that specifically blocks the infectivity of wild-type (wt) RRV and
of its sialic acid-independent variant nar3, in untreated as well as in neuraminidase-treated cells. The infectivity of a human
rotavirus was also inhibited, although to a lesser extent. MAb 2D9 blocks the binding of the variant to MA104 cells, while not
affecting the binding of wt RRV; in addition, this MAb blocked the attachment of a recombinant glutathione S-transferase
(GST)–VP5 fusion protein, but did not affect the binding of GST–VP8. Altogether these results suggest that MAb 2D9 is
directed to the neuraminidase-resistant receptor. This receptor seems to mediate the direct attachment of the variant to the
cell, through VP5, while the receptor is used by wt RRV for a secondary interaction, after its initial binding to sialic acid,
through VP8. MAb 2D9 interacts specifically with the cell surface by indirect immunofluorescence, immunoelectron
microscopy, and FACS. By a solid-phase immunoisolation technique, MAb 2D9 was found to react with three proteins of ca.
47, 55, and 220 kDa, which might form a complex. © 2000 Academic PressINTRODUCTION
The initial event in the interaction of a virus with the
host cell is the attachment of the virus to receptors in the
cell membrane. Attachment is mediated by a variety of
moieties on host cells ranging from the general, such as
sialic acid (SA), to specific extracellular integral mem-
brane proteins. Any cell surface entity that mediates this
attachment is defined as a viral receptor; consequently
the expression of the receptor on specific cells or tissues
in the whole host is a major determinant of the route of
virus entry into the host, the pattern of virus spread, and
the resulting pathogenesis (Haywood, 1994). An under-
standing of the mechanisms of viral cell attachment may
provide insight into the tissue tropism of a particular
virus, as well as potential treatments for viral diseases.
Rotaviruses are the leading cause of morbidity and
mortality, due to acute gastroenteritis, in children under 2
years of age (Kapikian and Chanock, 1996). These vi-
ruses, members of the family Reoviridae, are nonenvel-
oped and possess a genome of 11 segments of dsRNA
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160contained in a triple-layered protein capsid. The outer-
most layer is composed of two proteins, VP4 and VP7.
The smooth external surface of the virus is made up of
780 copies of the glycoprotein VP7, while 60 spike-like
structures, formed by dimers of VP4, extend about 12 nm
from the VP7 surface (Estes, 1996; Prasad et al., 1990).
VP4 has essential functions in the virus life cycle,
including receptor binding and cell penetration (Estes
and Cohen, 1989). The properties of this protein are
therefore important determinants of host range, viru-
lence, and induction of protective immunity. The infec-
tivity of rotaviruses is dependent on trypsin treatment
of the virus, and this proteolytic treatment results in
the specific cleavage of VP4 to polypeptides VP8 and
VP5 (Arias et al., 1996; Espejo et al., 1981; Estes et al.,
1981). The cleavage of VP4 does not affect cell binding
(Clark et al., 1981; Fukuhara et al., 1988; Kaljot et al.,
1988) and has been associated with the entry of the
virus by direct plasma membrane penetration (Kaljot et
al., 1988; Nandi et al., 1992; Ruiz et al., 1994). Recently,
it was shown that the virus uses both VP8 and VP5
proteins to bind to the surface of MA104 cells in a
SA-dependent and -independent manner, respectively
(Za´rate et al., 2000). The role of VP7 during the early
interactions of the virus with the cell is not clear,
although it has been shown that it can modulate some
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ceptor binding (Me´ndez et al., 1996).
Rotavirus infection is highly restricted in vivo to the
mature villus tip cells of the small intestine. The infection
in vitro is also restricted, being most permissive in a
variety of epithelial cell lines of renal and intestinal origin
(Kapikian and Chanock, 1996). The high degree of selec-
tivity of these viruses suggests the presence of specific
receptors in the surface of susceptible cells, which might
be at least one of the factors responsible for determining
the virus tropism.
Some rotaviruses of animal origin bind to the cell
surface through a SA-containing cell receptor (Ciarlet
and Estes, 1999; Fukudome et al., 1989; Keljo and Smith,
1988; Me´ndez et al., 1993). We have isolated variants
from a SA-dependent rhesus rotavirus (RRV) that no
longer depend on the presence of SA to bind and thus to
infect the cell. The characterization of these variants
showed that binding to SA is not an essential step for
infection of cells by SA-dependent animal rotaviruses; it
also showed that the initial interaction with SA can be
superseded by an interaction with a secondary receptor
[neuraminidase (NA)-resistant] that might be responsi-
ble, at least in part, for the tropism of these viruses
(Me´ndez et al., 1993). In contrast to animal rotaviruses,
most, if not all, human rotaviruses do not require SA to
infect the cells (Ciarlet and Estes, 1999; Keljo and Smith,
1988).
Based on competition experiments among strains of
human and animal origin, together with a SA-indepen-
dent RRV variant, it was established that the interaction
of rotavirus with its host cell is a multistep process in
which a SA-containing component, a SA-independent
molecule, and probably a third unidentified molecule are
involved (Me´ndez et al., 1999).
Recently, it was reported that VP4 and VP7 contain
integrin ligand sequences, and peptides containing
these ligand motifs and monoclonal antibodies (MAbs) to
the respective integrins inhibited the infectivity of the
simian rotavirus strain SA11 and of the human rotavirus
strain RV5, implicating a2b1 and a4b1 integrins in the
cell entry of these viruses (Coulson et al., 1997; Hewish
et al., 2000).
To identify other possible cell surface molecules in-
volved in the process of rotavirus entry we have gener-
ated MAbs directed to MA104 cells. In this work we
report the isolation and characterization of a MAb di-
rected to the surface of these cells that is able to spe-
cifically prevent the infectivity of the SA-dependent RRV
and of its NA-resistant variant nar3.
RESULTS
Isolation and screening of hybridomas. We were inter-
ested in isolating a MAb directed to the NA-resistant
rotavirus receptor. Thus, hybridomas were prepared frommice immunized with whole NA-treated MA104 cells.
Approximately 2500 hybridoma culture supernatants
were screened for their ability to block the infectivity of
the NA-resistant rotavirus variant nar3 in an immunoper-
oxidase focus reduction assay (Arias et al., 1987). One
hybridoma that efficiently inhibited nar3 infection was
subcloned three times by limiting dilution until a stable
antibody-producing clone was isolated. The MAb se-
creted by this clone, 2D9, was isotyped as IgM. In the
experiments described next, MAb 2D9 was used as a
purified fraction from ascites fluid.
Virus specificity of monoclonal antibody 2D9. The
specificity of MAb 2D9 was determined by its ability to
block the infectivity of the wt virus RRV, its SA-indepen-
dent variant nar3, and the human rotavirus strain Wa.
Preincubation of MA104 cells with different dilutions of
MAb 2D9 resulted in the reduction of the focus-forming
units (FFU) by 75% for nar3, by 60% for RRV, and by 25%
for Wa. This reduction in infectivity was dependent on the
concentration of MAb added to the cell monolayer. Pre-
incubation of the cells with a commercial, control mouse
IgM did not affect the infectivity of any of these viruses
(Fig. 1).
Given that the hybridoma secreting 2D9 was obtained
by immunizing mice with MA104 cells treated with NA,
we tested the ability of the MAb to prevent the infection
of the same three virus strains on cells treated with this
enzyme. Given the low level of infectivity of RRV under
these conditions (Me´ndez et al., 1993), the amount of
RRV used in this experiment was increased sixfold to
maintain a similar number of FFU per well. The blocking
activity of MAb 2D9 in NA-treated cells for the three virus
strains was essentially that observed in untreated cells
(Fig. 1).
To rule out the possibility that MAb 2D9 protected
MA104 cells by nonspecific masking of the cell surface,
the ability of this antibody to protect MA104 cells against
the infection of two other nonenveloped viruses was
evaluated. Figure 2 shows that 2D9 did not affect the
infectivity of either poliovirus type 3 or reovirus type 1 in
MA104 cells.
Altogether these results indicate that MAb 2D9 is able
to specifically block the infectivity of rotaviruses RRV and
nar3, and to a lesser extent that of the human strain Wa,
and that, most likely, the epitope recognized by this MAb
does not involve SA.
MAb 2D9 prevents the binding of nar3 but not that of
RRV. Since MAb 2D9 was able to significantly block the
infectivity of both RRV and its SA-independent variant
nar3 in MA104 cells, we next asked whether the inhibi-
tion of infectivity was due to the prevention of binding of
the viruses to the cell surface. For this, we used a
nonradioactive binding assay in which the cell-bound
virus was detected by a specific enzyme-linked immu-
nosorbent assay (ELISA) (Za´rate et al., 2000). In this
experiment, a suspension of MA104 cells was preincu-
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162 LO´PEZ ET AL.bated with different dilutions of either 2D9 or a control
mouse IgM for 1 h at 4°C; after removal of the excess
antibody the cells were incubated with a fixed amount of
either RRV or nar3. We found that while the preincubation
of the cells with 2D9 did not affect the binding of wt RRV,
the binding of nar3 was reduced in a concentration-
dependent manner up to about 25% of that of the control
cells (Fig. 3). The binding of the human strain Wa, in the
presence of either 2D9 or IgM, was not significantly
affected (not shown).
FIG. 1. MAb 2D9 blocks rotavirus infectivity in neuraminidase-treated
control IgM were added to monolayers of MA104 in 96-well plates th
h at 37°C. After incubation with the antibodies, the cells were washed
per well to both treated and untreated cells, with the exception of RRV i
under these conditions is reduced five- to six-fold. After 1 h of adsorp
proceed for 16 h at 37°C, at which time the cells were fixed and immu
as a percentage of the virus infectivity obtained when the cells were pr
five independent experiments performed in duplicate is shown.
FIG. 2. Blocking specificity of MAb 2D9. The indicated concentra-
tions of purified 2D9 were added to monolayers of MA104 in 96-well
plates for 1 h at 37°C and washed twice with PBS and then, approxi-
mately 2 3 103 FFU of nar3, reovirus type 1, or poliovirus type 3 was
added per well. After 1 h of adsorption at 37°C, the viral inoculum was
removed, and the infection was left to proceed for 16 h at 37°C, at
which time the cells were fixed and immunostained, as described
under Materials and Methods. Data are expressed as percentage of
the virus infectivity obtained when the cells were preincubated withn
t
PBS as a control. The arithmetic mean 6 standard error from two
independent experiments is shown.We have recently shown that RRV initially binds to the cell
surface through the VP8 domain of VP4, while nar3 binds
through VP5 (Za´rate et al., 2000). Since 2D9 is able to inhibit
the binding of nar3 but not that of RRV, we next asked
whether this MAb was able to differentially prevent the
binding of recombinant VP5 and VP8 proteins, which have
been previously shown to bind specifically to the cell sur-
face (Za´rate et al., 2000). For this, a suspension of MA104
ells was preincubated with MAb 2D9, or a mouse IgM as
ontrol, and then a constant amount of either glutathione
-transferase (GST)–VP5 or GST–VP8 fusion proteins pro-
uced in bacteria was added. The cell-bound recombinant
roteins were detected by ELISA as previously described
Za´rate et al., 2000). Figure 4 shows that while the binding
f GST–VP8 was not affected by preincubation of the cells
ith either 2D9 or the IgM control, the binding of GST–VP5
as reduced to about 30% of the control value with no
ntibody. Altogether these results suggest that MAb 2D9
ight be recognizing the same molecule used by the NA-
esistant variant nar3 to interact with the cell, through its
P5 protein.
The epitope recognized by 2D9 localizes to the surface
f MA104 cells. The cellular localization of the epitope
ecognized by MAb 2D9 was investigated by immuno-
lectron microscopy of MA104 cells. Figure 5A shows
hat MAb 2D9 labeled primarily the surface of the cells as
udged by the deposition of the peroxidase substrate,
AB, in the plasma membrane, whereas in the control
ells, incubated with a mouse IgM, this pattern was not
bserved (Fig. 5B). The DAB substrate stained only one
ace of the cells due to the fact that fixation and immu-
ntreated MA104 cells. The indicated concentrations of purified 2D9 or
been either treated (solid symbols) or not (open symbols) with NA for
with PBS and then 2 3 103 FFU of RRV, nar3, or Wa viruses was added
eated cells, where 1.2 3 104 FFU was used, since the infectivity of RRV
37°C, the viral inoculum was removed, and the infection was left to
ned, as described under Materials and Methods. Data are expressed
ted with PBS as a control. The arithmetic mean 6 standard error fromand u
at had
twice
n NA-tr
tion at
nostaiostaining were done while the cells were still bound to
he surface of the flask.
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163A MAb TO THE SURFACE OF MA104 CELLS BLOCKS ROTAVIRUS INFECTIVITYThe presence of the epitope recognized by 2D9 on the
cell surface was further confirmed by indirect immuno-
fluorescence of unpermeabilized MA104 cells. MAb 2D9
recognized an epitope that was distributed in a patched
pattern on the surface of the cells, which was more
clearly observed in the junction between cells (Fig. 5C).
Control cells stained with an IgM did not show this
pattern (Fig. 5D). Also, using flow cytometric analysis, we
FIG. 3. Binding of RRV and nar3 viruses to cells in the presence of
MAb 2D9. The indicated amounts of MAb 2D9 or a control IgM were
preincubated with 5 3 104 MA104 cells in suspension for 1 h at 4°C.
he excess, unbound antibody was removed, and then 300 ng of either
RV or nar3 purified virus particles was added, and the mixture was
urther incubated for 1 h at 4°C. The amount of virus bound to cells was
etermined by an ELISA as described under Materials and Methods.
ata are expressed as percentage of the virus binding obtained when
he virus particles were preincubated with PBS as a control. The
rithmetic mean 6 standard error from two independent experiments
erformed in duplicate is shown.
FIG. 4. Binding of recombinant proteins GST–VP8 and GST–VP5 to
cells in the presence of MAb 2D9. MAb 2D9 or a control IgM (100
mg/ml) was preincubated with 5 3 104 MA104 cells in suspension for
1 h at 4°C. The excess, unbound antibody was removed, and then 1.5
mg of affinity-purified GST–VP5 or GST–VP8 was added, and the mix-
ture was further incubated for 1 h at 4°C. The amount of cell-bound
protein was determined by ELISA as described under Materials and
Methods. Data are expressed as percentage of the recombinant pro-
tein binding obtained when the fusion proteins were preincubated with
PBS as a control (w/o MAb). The arithmetic mean 6 standard error from
two independent experiments performed in duplicate is shown.found that 2D9 was able to bind to the surface of MA104
cells (Fig. 5E), as predicted if directed to a virus receptor
structure.
Solid-phase immunoisolation of MA104 cell proteins by
MAb 2D9. Attempts to immunoprecipitate proteins from a
cell lysate with MAb 2D9 were unsuccessful. Thus, to
determine the cell surface protein to which the MAb was
directed, we performed a solid-phase immunoisolation
technique (SPIT) assay, in which either MAb 2D9 or a
control IgM were adsorbed to wells of an ELISA plate.
Total MA104 cell lysates labeled metabolically with 35S or
FIG. 5. Monoclonal antibody 2D9 interacts with the surface of MA104
cells. (A and B) Electron micrographs of immunoperoxidase staining of
MA104 cells. Immunomarking was performed directly on MA104 cell
monolayers, which were incubated with (A) MAb 2D9 (10 mg/ml) or with
(B) a control IgM (10 mg/ml) and then stained with peroxidase-conju-
ated goat anti-mouse IgM and DAB as substrate. The cells were then
etached from the flasks, postfixed with 1% OsO4, and processed for
electron microscopy as detailed under Materials and Methods. (C and
D) Indirect immunofluorescence of MA104 cells. Cells were incubated
with MAb 2D9 (10 mg/ml; C) or with a control IgM (10 mg/ml; D) and then
stained with affinity-purified goat anti-mouse IgM antibodies conju-
gated to fluorescein isothiocyanate. (E) Binding of MAb 2D9 to MA104
cells as determined by flow cytometry. Cells were incubated either with
MAb 2D9 (20 mg/ml, solid line) or with IgM (20 mg/ml, dashed line) and
tained with affinity-purified goat anti-mouse IgM antibodies conju-
ated to fluorescein isothiocyanate. The amount of IgM bound was
ssayed by flow cytometry as described under Materials and Methods.with sulfo-NHS-biotin, which labels proteins exposed in
the cell surface (since it is a membrane-impermeable
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164 LO´PEZ ET AL.reagent), were added to the antibody-coated wells. The
wells were later extensively washed, and the proteins
that remained bound were released with Laemmli sam-
ple buffer and analyzed by SDS–PAGE and fluorography
(for 35S-labeled proteins) or transferred to nitrocellulose
for the biotin-labeled proteins) and stained with strepta-
idin coupled to peroxidase (Fig. 6). It can be observed
hat MAb 2D9 captured from the total protein cell lysate
group of three proteins of ca. 47, 55, and 220 kDa,
hich were not recognized by the control IgM. These
hree proteins must be exposed on the surface of the
ell, since the SPIT assay performed with the biotin-
abeled polypeptides showed three proteins with the
ame molecular masses. Again, when the biotin-labeled
ysate was incubated in a well coated with the control
gM, no biotinylated proteins were observed. These re-
ults suggest that MAb 2D9 interacts with a cell surface
rotein that might be forming a complex of at least three
roteins or that the three proteins that are captured by
FIG. 6. Solid-phase immunoisolation of MA104 cell proteins by MAb
D9. Cell lysates metabolically labeled with 35S ([35S]Met-labeled pro-
eins) or with sulfo-NHS-biotin (biotin-labeled proteins) were added to
ntibody (2D9 or IgM)-coated wells. After incubation, the wells were
ashed, and the proteins that remained bound to the wells were
eleased with Laemmli sample buffer. The samples were analyzed by
DS–PAGE and fluorography (for 35S-labeled proteins) or by Western
blot (for the biotin-labeled proteins) staining with streptavidin coupled
to peroxidase, as indicated under Materials and Methods. MW, molec-
ular weight markers.D9 share a common epitope recognized by the anti-
ody.
i
rDISCUSSION
It has been known for some time that rotaviruses can
nteract with the surface of susceptible cells by at least
wo different mechanisms; some rotaviruses of animal
rigin attach to a sialic acid-containing molecule, while
otaviruses of human origin bind through a neuramini-
ase-resistant compound (Ciarlet and Estes, 1999; Men-
ez et al., 1993). However, it has been recently shown
hat the initial interaction of animal rotaviruses with SA is
ot essential, since variants that bind and infect cells in
SA-independent manner have been isolated from the
A-dependent RRV (Ciarlet and Estes, 1999; Ludert et al.,
996; Mendez et al., 1993).
One of the strategies that has been successfully used
o identify the cell receptors for viruses belonging to
everal different families has been the isolation of hy-
ridomas that secrete MAbs directed to the surface of
usceptible cells, which are able to block virus entry. The
utative receptors for measles virus (Dunster et al.,
994), Sindbis virus (Wang et al., 1992), enterovirus 70
Karnauchow et al., 1996), echoviruses (Bergelson et al.,
994), and vaccinia virus (Chang et al., 1995), among
ther examples, have been identified following this strat-
gy.
Following this approach, we isolated a hybridoma that
ecretes a MAb directed against the surface of NA-
reated MA104 cells, a highly permissive cell line for
otavirus. This MAb (2D9), of IgM isotype, is able to
pecifically block the infectivity of both wt RRV and its
ariant nar3, and to a lesser extent, the infectivity of the
uman strain Wa. MAb 2D9 also blocks the infectivity of
hese viruses in NA-treated cells.
The antigen recognized by 2D9 is present on the
urface of MA104 cells as judged by fluorescence-acti-
ated cell sorting (FACS) analysis, immunofluorescence,
nd immunoelectron microscopy. Using the first two
ethods we screened several cell lines for the presence
f this antigen. We found that MAb 2D9 specifically
ecognized the surface of CV-1, CaCo2, and COS7 cells,
ll susceptible to rotavirus infection. However, this MAb
lso reacted with the surface of Hep-2, L, CHO, and BHK
ells, which are much less susceptible to infection by
otaviruses (Espinosa et al., unpublished results), indi-
ating that the antigen recognized by 2D9 is not the only
actor that determines the tropism of these viruses.
A number of glycoconjugates have been shown to
ind to, and to block the infectivity of, SA-dependent
nimal rotavirus strains, and some of them have been
uggested to play a role as possible receptors, like GM3
angliosides in newborn piglet intestine (Rolsma et al.,
998), GM1 in LLC-MK2 cells (Superti and Donelli, 1991),
nd 300 to 330-kDa glycoproteins in murine enterocytes
Bass et al., 1991). More recently, it was reported that
ntegrins a2b1 and a4b1 are involved in the entry of
otaviruses (Coulson et al., 1997). The fact that the
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face of CHO and L cells, which do not express a2 or a4
ntegrins (Hewish et al., 2000; Zhang and Racaniello,
997), and the fact that the reported molecular weight for
hese integrins does not coincide with that of the pro-
eins detected by 2D9 suggest that this MAb recognizes
molecule different from integrins a2b1 and a4b1.
We have recently reported that wt RRV interacts ini-
tially with SA residues on the surface of MA104 cells,
through the VP8 domain of its VP4 protein. We proposed
that this initial interaction is subsequently followed by a
second interaction of the VP5 domain of VP4 with a
NA-resistant cell receptor. We also showed that the SA-
independent variant nar3 is able to interact directly with
the cell surface through VP5, obviating the first VP8–SA
interaction (Za´rate et al., 2000). In this work we have
found that MAb 2D9, despite inhibiting the infectivity of
both wt RRV and nar3 viruses, competes only the attach-
ment of the variant, suggesting that it blocks the infec-
tivity of the wt virus at a postattachment step, in agree-
ment with our previous observations. In accordance with
these results, we found that 2D9 blocks the binding of
the GST–VP5 fusion protein, while it does not affect the
attachment of the GST–VP8 recombinant polypeptide
(Fig. 4). Taken together, these results suggest that the
epitope recognized by 2D9 is independent of sialic acid
and is probably present in the cell receptor that interacts
with VP5 or in a molecule closely associated with it.
Based on an infection competition assay, designed to
detect competition for cell surface molecules at both
attachment and postattachment steps (Mendez et al.,
1999), we found that the human strain Wa efficiently
competed the infectivity of the variant nar3 both in un-
treated and in NA-treated cells. This competition was
nonreciprocal since nar3 did not compete the infectivity
of Wa. The fact that the competition between the two
NA-resistant strains, nar3 and Wa, was not reciprocal
indicates that they bind to different molecules. In addi-
tion, the SA-dependence phenotype clearly differentiates
RRV from nar3 and Wa, suggesting the existence of at
least three cellular structures involved in rotavirus cell
infection, with at least one being shared by human,
SA-dependent animal, and NA-resistant variant strains.
The antigen recognized by 2D9 on the surface of the cell
might represent one of these interactions.
The list of viruses that have more than one interaction
with the cell surface during cell entry is growing (Hay-
wood, 1994; Norkin, 1995), indicating that our initial view
that the virus–receptor interactions resembled those of
simple ligands with their receptors was not completely
true. It is becoming more and more apparent that the
interaction of a virus with the surface of its host cell,
which ultimately leads to the entry of the virus into the
cell’s cytoplasm, is a dynamic process in which more
than one virus–cell interaction often takes place and in
which conformational changes of both viral and host cellproteins might occur (Haywood, 1994; Norkin, 1995; Ol-
son et al., 1999). Furthermore, it has become apparent
that some viruses may use more than one receptor to
gain access into their host cells (Baranowski et al., 2000;
Thoulouze et al., 1998; Tufano, 1997).
Despite our efforts, it was not possible either to im-
munoprecipitate or to detect by Western blots the mole-
cule(s) recognized by MAb 2D9. However, by a solid-
phase immunoisolation technique, 2D9 specifically inter-
acted with three proteins that were present on the
surface of the cell, as judged by the fact that they could
be labeled with a reagent that is impermeable to the cell
membrane. Although it is possible that these three pro-
teins contain a common epitope recognized by MAb 2D9,
it seems more likely that the proteins might be forming a
complex, which remains as such under the conditions
used to lyse the cells, with only one of them being
recognized by 2D9. The identity of these proteins is
currently under investigation.
The fact that neither 2D9 nor any of the anti-integrin
antibodies that have been assayed so far are able to
completely block the infectivity of rotaviruses [this work
and Coulson et al., (1997)], together with the finding that
MAb 2D9 reacts with the surface of cells that are poorly
susceptible to rotavirus, supports our idea that the inter-
action of rotavirus with its host cell is a multistep process
(Mendez et al., 1999) that involves interactions with sev-
eral different molecules on the cell surface. The exquis-
ite tropism of rotaviruses, which in vivo infect only a very
narrow set of cells in the intestine, might be explained if
only this type of cell possesses on its surface the appro-
priate combination of the required receptor molecules,
which might be present individually in many different cell
types. It remains to be determined how many cell surface
molecules are involved in the complex process of rota-
virus cell attachment and penetration and the role they
may play.
MATERIALS AND METHODS
Cells, viruses, and monoclonal antibodies. MA104 and
L929 cells (L cells) were cultured in Eagle’s minimal
essential medium (MEM) supplemented with 10% fetal
bovine serum. Rotavirus strains RRV and Wa were orig-
inally obtained from H. B. Greenberg (Stanford University,
Stanford, CA), and rotavirus variant nar3 has been de-
scribed previously (Me´ndez et al., 1993). RRV, Wa, and
nar3 viruses were propagated in MA104 cells as previ-
ously described (Espejo et al., 1980). Reovirus serotype 1
was obtained from C. Ramos (Instituto Nacional de Salud
Pu´blica, Cuernavaca, Morelos, Me´xico) and was grown
in L cells as described (Cuadras et al., 1997). Poliovirus
type 3 was obtained from R. M. del Angel (CINVESTAV,
Mexico D.F., Mexico) and was grown in MA104 cells.
Rabbit polyclonal antibody against reovirus type 1 was
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166 LO´PEZ ET AL.kindly provided by T. Dermody (Vanderbilt Medical
School, Nashville, TN).
To prepare purified virus, virus-infected cells were
harvested after complete cytopathic effect was attained,
the cell lysate was frozen–thawed twice, and the virus
was pelleted by centrifugation for 60 min at 25,000 rpm at
4°C in the SW28 rotor (Beckman). The virus pellet was
resuspended in TNC buffer [10 mM Tris–HCl (pH 7.5), 140
mM NaCl, 10 mM CaCl2], extracted with Freon, and
subjected to isopicnic centrifugation in CsCl as previ-
ously described (Espejo et al., 1981). The protein content
of the purified triple-layered particles was determined by
the Bradford protein assay (Bio-Rad).
The infectious titer of the viral preparations was ob-
tained by an immunoperoxidase focus assay in MA104
cells grown in 96-well tissue culture plates, as described
(Arias et al., 1987). Titers are expressed as focus-forming
units per milliliter. When indicated, cells were treated
with 20 mU/ml of NA from Arthrobacter ureafaciens (Sig-
ma Chemical Co.) for 1 h at 37°C. After two washes with
PBS [0.2 M NaCl, 2.7 mM KCl, 1.4 mM KH2PO4, 0.8 mM
a2HPO4 (pH 7.4)], the cells were infected as described
(Me´ndez et al., 1993).
Production of monoclonal antibodies. Confluent mono-
ayers of MA104 cells were washed and brought into a
ingle-cell suspension by incubation with 5 mM EDTA in
BS for 10 min at 37°C and dispersed by gentle pipetting.
he cell suspensions were centrifuged at 1000 rpm for 1
in at 4°C, washed, resuspended into PBS, and treated
ith 20 mU of A. ureafaciens neuraminidase (Sigma Chem-
cal Co.) for 1 h at 37°C with gentle rocking. The cells were
hen washed twice with PBS and resuspended in PBS and
heir concentration was determined with a hemocytometer.
nbred female BALB/c mice (8 weeks old) were immunized
ntraperitoneally with 7.5 3 106 whole MA104 cells, pre-
reated with NA, at 2-week intervals (four times total). Anti-
ody production was monitored by measuring the ability of
he sera to block the infectivity of nar3 and RRV viruses (see
bove). Two days prior to cell fusion, mice were primed by
ail vein injection of 1 3 107 whole MA104 cells in PBS,
pretreated with NA. Spleens from immunized mice were
fused with FOX myeloma cells essentially as described by
Padilla-Noriega et al., (1993). Supernatants from viable hy-
ridoma cultures were screened for the presence of anti-
odies that blocked the infectivity of nar3 by an immuno-
eroxidase focus reduction assay, in MA104 cells grown in
6-well tissue culture plates, as previously described (Arias
t al., 1987). Hybridomas producing blocking antibodies
ere cloned three times by limiting dilution and their su-
ernatants were retested.
The blocking activity of one hybridoma, named 2D9,
as confirmed after repeated tests. This MAb was
hown to be of the IgM class by double immunodiffusion
sing isotype-specific antibodies (ICN). For production of
scites fluid containing MAb 2D9, 8-week BALB/c female
ice, primed intraperitoneally with 200 ml of Pristane,were inoculated with the 2D9 hybridoma. The ascitic
fluid was collected 2 weeks after the hybridoma immu-
nization, and the IgM fraction was obtained by dialysis of
the ascitic fluid in distilled water as described (Andrew et
al., 1997). The protein content of the purified IgM fraction
was determined by the Bradford protein assay (Bio-Rad)
and by OD280 reading.
Binding assays. The binding of purified rotavirus parti-
cles and of affinity-purified GST–fusion proteins to MA104
cells in suspension was performed by a nonradioactive
binding assay essentially as described by Za´rate et al.,
(2000). Briefly, a suspension of 5 3 104 cells preincubated
ith the appropriate dilution of MAb 2D9 or control IgM for
h at 4°C was mixed either with purified virus or with
ecombinant proteins (previously sonicated and centrifuged
or 2 min in the Eppendorf centrifuge) in MEM–1% bovine
erum albumin (BSA) in a final volume of 200 ml and incu-
bated for 1 h at 4°C with gentle mixing. The cell–virus or
cell–protein complexes were washed three times with ice-
cold PBS containing 0.5% BSA and then treated with 50 ml
of lysis buffer (LyB) [50 mM Tris(pH 7.5), 150 mM NaCl, 0.1%
Triton X-100]. In the last wash, the cells were transferred to
a fresh tube. The virus and recombinant proteins present in
the lysates were quantified by ELISAs. In all binding assays
of either virus or recombinant proteins, a binding control
with no cells was performed.
Capture ELISAs for rotavirus particles and GST–fusion
viral proteins. To detect the virus particles, goat and rabbit
polyclonal sera to rotavirus were used as capture (diluted
1:10,000) and detection (diluted 1:1500) antibodies, respec-
tively. The rotavirus proteins fused to GST were captured
with the goat anti-rotavirus serum and detected with a
rabbit serum to GST (diluted 1:1500). In general, the ELISA
was performed as follows: polystyrene 96-well plates were
coated with 100 ml of capture antibody diluted in PBS, for
2 h at 37°C. Residual free protein-binding sites were
blocked by incubation with 200 ml of 1% (w/v) BSA in PBS
for 2 h at 37°C. Incubation with 50 ml per well of viral or
protein antigen sample in lysis buffer for 1 h at 37°C was
followed by incubation with 50 ml per well of the appropriate
etection antibody (see above) diluted in 1% BSA in PBS.
inally, 50 ml per well of the respective alkaline phos-
hatase-conjugated anti-immunoglobulin serum [goat anti-
abbit IgG or goat anti-mouse IgG (diluted 1:1500), Kirker-
aard and Perry] was incubated for 1 h at 37°C, and then
igma 104 phosphatase substrate diluted in diethanol-
mine buffer [100 mM diethanolamine (pH 9.4), 1 mM
gCl2, 5 mM sodium azide] was added. The absorbance at
405 nm was recorded with a Microplate Autoreader EL311
(Bio-Tek Instruments).
Cloning, expression, and purification of GST–fusion
proteins. The cloning, expression, and purification of RRV
GST–VP8 and GST–VP5 proteins have been described
(Isˇa et al., 1997; Za´rate et al., 2000).Flow cytometry (FACS). MA104 cells grown to 80%
confluence were washed and brought into a single-cell
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167A MAb TO THE SURFACE OF MA104 CELLS BLOCKS ROTAVIRUS INFECTIVITYsuspension by incubation with 0.5 mM EDTA in PBS at
37°C and dispersed by gentle pipetting. Cells were col-
lected by low-speed centrifugation (200 g) and resus-
pended in ice-cold MEM without serum, and the cell
concentration was determined with a hemocytometer. In
each experiment, 5 3 105 cells were incubated with
either MAb 2D9 or IgM control antibody (20 mg/ml) for 1 h
t 4°C, washed twice with 2% fetal calf serum in PBS,
nd then incubated with fluorescein-conjugated anti-
ouse IgM antibodies (15 mg/ml; Biosourse, USA) for 1 h
at 4°C. Fluorescence-activated cell sorting analysis was
done using a FACScan flow cytometer and Cellquest
software (Becton Dickinson) with appropriate gating pa-
rameters.
Biotinylation of cell surface proteins. A single-cell sus-
pension of MA104 cells was prepared as described
above. Cells (1 3 107) were incubated for 30 min at 4°C
with water-soluble sulfo-NHS-biotin (2 mg/ml; Pierce) in
PBS, with occasional gentle mixing. Unreacted sulfo-
NHS-biotin was blocked by incubation with an equal
volume of 10 mM glycine in PBS for 30 min at 4°C, and
then the cells were washed twice with PBS and solubi-
lized with LyB supplemented with 1 mM PMSF, 20 mg/ml
aprotinin, and 20 mg/ml leupeptin for 10 min at 4°C. After
ysis the cells were centrifuged for 10 min at 3500 rpm in
he Eppendorf microfuge and the cell lysate was used for
he SPIT assay (see below).
Radiolabeling of MA104 cell proteins. MA104 cells
ere grown in 6-well plates (Costar) to approximately
0% confluence. Cell monolayers were washed twice
ith methionine-free MEM and incubated for 16 h in
adiolabeling medium [MEM with 1/20 the regular con-
entration of methionine, 10% dialyzed serum, and 100
mCi/ml Easy Tag Express-35S protein labeling mix (NEN)].
Labeled cells were washed twice with PBS and solubi-
lized with 1 ml of LyB as described above for the biotin-
labeled cells.
Solid-phase immunoisolation technique. Direct SPIT
was carried out essentially as described by Burns et al.,
(1988). ELISA 96-well plates were coated with 50 ml of
the antibody of interest (10 mg/ml) in PBS overnight at
°C. The plates were washed four times with PBS and
locked with 0.5% gelatin in PBS for 1 h at 37°C, followed
y addition of the radiolabeled or biotinylated cell ly-
ates. After overnight incubation at 4°C, unbound lysate
as removed and the plates were washed four times
ith wash buffer (PBS containing 0.01% SDS, 0.1% so-
ium deoxycholate, 1% Nonidet-P40). The bound pro-
eins were solubilized by addition of gel sample buffer
1% SDS, 5% 2-mercaptoethanol, 0.5 M urea, 50 mM
ris–HCl (pH 6.8), 10% glycerol, 0.0025% phenol red] and
oiling for 3 min. The samples were analyzed by SDS–
AGE and fluorography in the case of the 35S-labeled
proteins or by Western blot with streptavidin-peroxidase
and enhanced chemiluminiscence (ECL, Amersham), in
the case of the biotin-labeled proteins.Indirect immunofluorescence. Semiconfluent MA104
cells grown in coverslips were fixed with 2% formalde-
hyde, 0.25% glutaraldehyde in PBS, for 15 min at room
temperature, washed three times with PBS, and blocked
with 1 M glycine in PBS (w/v), for 1 h at room tempera-
ture. After three further washes, the cells were incubated
with 10 mg/ml of either MAb 2D9 or a control IgM (Sigma
Chemical Co.) for 1 h at room temperature. Finally, fol-
lowing two more washes, the cells were incubated with
a 1:20 dilution of a FITC-conjugated goat anti-mouse IgM
(Sigma Chemical Co.) for 1 h at room temperature. The
cells were washed three times and mounted on glass
slides in 80% glycerol in PBS. The slides were analyzed
by using a Bio-Rad MRC-600 confocal microscope and
CoMOS MPL-1000 software.
Immunoelectron microscopy. Confluent MA104 cells in
25-cm2 flasks were fixed with 2% formaldehyde, 0.25%
lutaraldehyde in PBS, for 30 min at 4°C, washed three
imes with PBS, and blocked with 1% BSA in PBS for 15
in at room temperature. After three washes, the cells
ere incubated with 10 mg/ml of either MAb 2D9 or a
control IgM (Sigma Chemical Co.) for 1 h at room tem-
perature. Finally, following two washes with PBS, the
cells were incubated with a 1:50 dilution of a peroxidase-
conjugated goat anti-mouse IgM (Sigma Chemical Co.)
for 1 h at room temperature. After three washes with
PBS, the cells were incubated with the peroxidase sub-
strate [0.5 mg/ml of DAB (Sigma Chemical Co.) in PBS
with 0.1% H2O2], for 15 min at 37°C, and the reaction was
stopped by removing the substrate and washing with
ice-cold PBS. The cells were then detached from the
flask with the aid of a rubber policeman, postfixed in 1%
osmium tetroxide, dehydrated, and embedded in Poly/
Bed 812/DMP30 (Polysciences, Warrington, PA); 30-mm
sections were obtained from selected areas of trimmed
blocks, floated onto formvar-coated nickel grids, and
counterstained for 5 min with a 2.5% uranyl acetate
solution in 40% ethanol. Sections were examined and
photographed in a Jeol JEM 1200 EXII electron micro-
scope.
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